Today: 8 June 2026
Browse Category

NSE:ADANIPORTS 13 November 2025 - 2 February 2026

India stock market today: Nifty, Sensex shut for Republic Day; tariffs, Axis Bank results in focus

India stock market today: Nifty, Sensex shut for Republic Day; tariffs, Axis Bank results in focus

Indian stock exchanges closed Monday for Republic Day after the Nifty 50 fell 0.95% Friday to 25,048.65, its sharpest weekly drop in four months. The Sensex ended at 81,537.70. Adani group shares slid after a U.S. regulator sought court approval in a fraud case. Markets reopen Tuesday ahead of the Feb. 1 Union Budget.
26 January 2026
·····
India Stock Market Wrap 28–29 November 2025: Sensex, Nifty Hover Near Record Highs as Rupee Hits New Low and GDP Jumps 8.2%

India Stock Market Wrap 28–29 November 2025: Sensex, Nifty Hover Near Record Highs as Rupee Hits New Low and GDP Jumps 8.2%

India’s Sensex closed at 85,706.67 on Friday, down 0.02%, while the Nifty 50 slipped 0.05% to 26,202.95, just below record highs. The rupee hit a record low as foreign investors remained net sellers, despite India posting its strongest quarterly growth in six quarters. Nifty Auto and Pharma led sector gains; IT and Oil & Gas lagged.
29 November 2025
·······
Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

Sensex, Nifty Close Flat on Nov 13, 2025; Bank Nifty Hits Record High, Asian Paints Jumps; Rupee Near 88.66 as CPI Prints Record Low

The Sensex closed nearly flat at 84,478.67 and the Nifty 50 at 25,879.15 on Thursday as investors paused ahead of Bihar election results. The Nifty Bank index hit a record intraday high near 58,616. Asian Paints surged to a 52-week high after strong earnings, while Mahindra & Mahindra and Adani Ports slipped. October CPI fell to 0.25% y/y, and the rupee ended at 88.6650 per US dollar.
13 November 2025
··········

Stock Market Today

  • Stock Market Update: Dow Expected to Weaken, Nasdaq to Gain After Sharp Dip; Oil Prices Surge Amid Middle East Conflict
    June 8, 2026, 9:06 AM EDT. The Dow Jones Industrial Average is set to weaken while the Nasdaq Composite is poised for gains after the S&P 500 experienced its worst day since October. This downturn follows renewed violence in the Middle East, with Iran striking Israel, escalating geopolitical tensions. Oil prices jumped significantly, reflecting concerns over supply disruptions linked to the conflict. Investors remain cautious as markets digest the impact of escalating regional instability on global economic outlooks.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
Go toTop